Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2005 Oct;28(9):806-9.
doi: 10.1007/BF03347570.

Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study

Affiliations
Multicenter Study

Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study

M F Erdogan et al. J Endocrinol Invest. 2005 Oct.

Abstract

Objective: Medullary thyroid carcinoma (MTC) frequently occurs in a sporadic form, but a substantial number of cases are hereditary and appear as part of the multiple endocrine neoplasia type 2 (MEN2) syndromes. Germline mutations in ret proto-oncogene have been shown to be the underlying cause of MEN2 syndromes.

Design: We carried out a multi-center study that aimed to perform mutational analysis of so called sporadic MTC patients.

Methods: Fifty-six MTC patients verified by histopathologic examination were subjected to genetic analysis. Exon 10, 11, 13, 14, 15 and 16 of the ret gene were analyzed by DNA sequencing and restriction enzyme digestion method.

Results: Among 56 apparently sporadic MTC patients, we identified 6 (10.7%) ret germline mutation carriers. Three individuals carried mutations at codon 634 in exon 11, one at codon 618 in exon 10, and two at codon 804 in exon 14. Identification of the predisposition gene mutation has allowed DNA-based strategy for direct mutation detection in patients with apparently sporadic MTCs. A substantial number of patients with apparently sporadic MTC carried germline mutations and 50% of their first degree relatives are expected to have or to develop MTC and/or other endocrine tumors.

Conclusions: These results indicate the importance of careful genetic surveillance of any patient with apparently sporadic MTCs.

PubMed Disclaimer

References

    1. Nature. 1997 Jun 12;387(6634):717-21 - PubMed
    1. J Intern Med. 1995 Oct;238(4):343-6 - PubMed
    1. J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71 - PubMed
    1. Nature. 1993 Jun 3;363(6428):458-60 - PubMed
    1. Hum Mol Genet. 1994 Nov;3(11):1939-43 - PubMed

Publication types

LinkOut - more resources